Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation.

Müller MH, Drieschner N, Focken T, Bartnitzke S, Winter N, Klemke M, Bullerdiek J.

Anticancer Res. 2013 Aug;33(8):3069-78.

PMID:
23898062
2.

Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules.

Eszlinger M, Krogdahl A, Münz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bösenberg E, Drieschner N, Scholz M, Hegedüs L, Paschke R.

Thyroid. 2014 Feb;24(2):305-13. doi: 10.1089/thy.2013.0278.

PMID:
23837487
3.

Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer.

Rippe V, Flor I, Debler JW, Drieschner N, Rommel B, Krause D, Junker K, Bullerdiek J.

Mol Cytogenet. 2012 Oct 15;5(1):40. doi: 10.1186/1755-8166-5-40.

4.

Monosomy and ring chromosome 13 in a thyroid nodular goiter-do we underestimate its relevance in benign thyroid lesions?

Sendt W, Rippe V, Flor I, Drieschner N, Bullerdiek J.

Cancer Genet. 2012 Mar;205(3):128-30. doi: 10.1016/j.cancergen.2012.01.010.

PMID:
22469512
5.

MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups.

Markowski DN, Bartnitzke S, Löning T, Drieschner N, Helmke BM, Bullerdiek J.

Int J Cancer. 2012 Oct 1;131(7):1528-36. doi: 10.1002/ijc.27424.

6.

Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.

Klemke M, Drieschner N, Belge G, Burchardt K, Junker K, Bullerdiek J.

Genes Chromosomes Cancer. 2012 Apr;51(4):402-8. doi: 10.1002/gcc.21925.

PMID:
22179975
7.

Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue.

Kloth L, Belge G, Burchardt K, Loeschke S, Wosniok W, Fu X, Nimzyk R, Mohamed SA, Drieschner N, Rippe V, Bullerdiek J.

BMC Clin Pathol. 2011 Nov 4;11:13. doi: 10.1186/1472-6890-11-13.

8.

Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics.

Drieschner N, Rippe V, Laabs A, Dittberner L, Nimzyk R, Junker K, Rommel B, Kiefer Y, Belge G, Bullerdiek J, Sendt W.

Cancer Genet. 2011 Jul;204(7):366-74. doi: 10.1016/j.cancergen.2011.03.008.

PMID:
21872823
9.

On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.

Klemke M, Drieschner N, Laabs A, Rippe V, Belge G, Bullerdiek J, Sendt W.

Cancer Genet. 2011 Jun;204(6):334-9. doi: 10.1016/j.cancergen.2011.05.001.

PMID:
21763631
10.

6p21 rearrangements in uterine leiomyomas targeting HMGA1.

Nezhad MH, Drieschner N, Helms S, Meyer A, Tadayyon M, Klemke M, Belge G, Bartnitzke S, Burchardt K, Frantzen C, Schmidt EH, Bullerdiek J.

Cancer Genet Cytogenet. 2010 Dec;203(2):247-52. doi: 10.1016/j.cancergencyto.2010.08.005.

PMID:
21156240
11.

Cell culture and senescence in uterine fibroids.

Markowski DN, Bartnitzke S, Belge G, Drieschner N, Helmke BM, Bullerdiek J.

Cancer Genet Cytogenet. 2010 Oct 1;202(1):53-7. doi: 10.1016/j.cancergencyto.2010.06.010.

PMID:
20804922
12.

An unbalanced t(15;18)(q21-q22;p11) as the sole cytogenetic aberration in a patient with B-cell chronic lymphocytic leukemia.

Kiefer Y, Drieschner N, Förster H, Tiemann M, Schulte C, Rommel B, Bullerdiek J.

Cancer Genet Cytogenet. 2010 Jul 1;200(1):65-9. doi: 10.1016/j.cancergencyto.2010.03.008. No abstract available.

PMID:
20513537
13.

The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas.

Rippe V, Dittberner L, Lorenz VN, Drieschner N, Nimzyk R, Sendt W, Junker K, Belge G, Bullerdiek J.

PLoS One. 2010 Mar 3;5(3):e9485. doi: 10.1371/journal.pone.0009485.

14.

Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.

Klemke M, Meyer A, Nezhad MH, Bartnitzke S, Drieschner N, Frantzen C, Schmidt EH, Belge G, Bullerdiek J.

Genes Chromosomes Cancer. 2009 Feb;48(2):171-8. doi: 10.1002/gcc.20627.

PMID:
18980243
15.

Chromosomal assignment of canine THADA gene to CFA 10q25.

Soller JT, Beuing C, Murua Escobar H, Winkler S, Reimann-Berg N, Drieschner N, Dolf G, Schelling C, Nolte I, Bullerdiek J.

Mol Cytogenet. 2008 Jun 3;1:11. doi: 10.1186/1755-8166-1-11.

16.

A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas.

Drieschner N, Kerschling S, Soller JT, Rippe V, Belge G, Bullerdiek J, Nimzyk R.

Gene. 2007 Nov 15;403(1-2):110-7.

PMID:
17889454
17.

Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.

Drieschner N, Belge G, Rippe V, Meiboom M, Loeschke S, Bullerdiek J.

Thyroid. 2006 Nov;16(11):1091-6.

PMID:
17123335
18.

Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas.

Rippe V, Drieschner N, Meiboom M, Murua Escobar H, Bonk U, Belge G, Bullerdiek J.

Oncogene. 2003 Sep 4;22(38):6111-4.

PMID:
12955091
19.

Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19.

Rogalla P, Helbig R, Drieschner N, Flohr AM, Krohn M, Bullerdiek J.

Anticancer Res. 2002 Jul-Aug;22(4):1987-92.

PMID:
12174875
20.

Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma.

Blank C, Schoenmakers EF, Rogalla P, Huys EH, van Rijk AA, Drieschner N, Bullerdiek J.

Cytogenet Cell Genet. 2001;95(1-2):17-9.

PMID:
11978964

Supplemental Content

Loading ...
Support Center